Logo

Ortho Clinical Diagnostics' Total Antibody Test Receives the US FDA's Emergency Use Authorization for COVID-19

Share this

Ortho Clinical Diagnostics' Total Antibody Test Receives the US FDA's Emergency Use Authorization for COVID-19

Shots:

  • The US FDA has granted EUA to Ortho’s total Ab assay for COVID-19- the VITROS immunodiagnostic products Anti-SARS-CoV-2 total reagent pack and calibrators and is considered as one of the first high-throughput- automated COVID-19 Ab tests to be granted EUA
  • The test can be run on Orthos’ VITROS XT 7600 Integrated System- the VITROS 3600 Immunodiagnostic System- the VITROS 5600 Integrated System and will soon be available on VITROS ECi/ECiQ Immunodiagnostic System
  • The VITROS Anti-SARS-CoV-2 Ab tests are designed to be performed by laboratory professionals and cannot be directly used by patients. The test screens plasma donations for convalescent plasma therapy and when combined with molecular test- it monitors disease progression by measuring Ab appearance in the blood

Click here ­to­ read full press release/ article | Ref: Ortho Clinic Diagnostic | Image:  Ortho Clinic Diagnostic


Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions